Persistent “stigma” and ignorance is holding back the development of new drugs to treat psychiatric conditions such as ...
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) ...
The Windsor Framework marks a significant change in the UK's post-Brexit regulatory space, particularly for the ...
CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted ...
today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for active immunization for the ...
The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...